Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHYR.L Regulatory News (HYR)

  • There is currently no data for HYR

Joint Share Ownership Awards

7 May 2015 07:00

RNS Number : 4033M
HydroDec Group plc
07 May 2015
 

7 May 2015

 

Hydrodec Group plc

("Hydrodec" or the "Company")

 

Joint Share Ownership Awards

 

Hydrodec Group plc (AIM: HYR), the clean-tech industrial oil re-refining group, announces that on 6 May 2015, beneficial interests in 2,583,333 ordinary shares of 0.5p each in the capital of the Company ("Shares") were awarded to members of the senior executive leadership team as awards under the Company's Joint Share Ownership Plan A (the "JSOP") (the "JSOP Shares").

 

Pursuant to the Company's remuneration policy, annual performance bonus awards to members of the senior executive leadership team are made partly in cash at the time and partly through deferred interests in Shares held under the JSOP. As set out in the Company's 2013 Annual Report1, the senior executive leadership team agreed to defer fifty per cent of their respective annual bonus awards for 2013 into Shares to be held under the JSOP. The awards in respect of the JSOP Shares have been made in part satisfaction of this deferred element of the annual bonus awards for 2013. The reference price used in determining the number of JSOP Shares awarded is 10.8p per Share, being the average closing mid-market price per Share on dealing days in January 2014.

 

As part of the above awards:

 

· Ian Smale, Chief Executive, was granted a beneficial interest in 853,422 JSOP Shares for nil cost. Following this transaction, Ian Smale has a beneficial interest in 1,981,436 Shares (representing approximately 0.27 per cent of the issued voting Shares); and

 

· Chris Ellis, Chief Financial Officer, was granted a beneficial interest in 691,964 JSOP Shares for nil cost. Following this transaction, Chris Ellis has a beneficial interest in 2,038,802 Shares (representing approximately 0.27 per cent of the issued voting Shares).

 

The JSOP Share awards have been made in respect of unallocated Shares held by the Company's employee benefit trust (the "EBT"). Consequently, the award of the JSOP Shares does not alter the total number of Shares in issue or which have voting rights. 

 

Under the JSOP, the JSOP Shares are held by participants jointly with the trustee of the EBT pursuant to the terms of joint ownership agreements entered into between the EBT and each respective participant. If a fixed share price hurdle is achieved on or before 31 January 2016 (being two years after the original date of award of the annual bonus for 2013), the participants will benefit from the growth in value of their respective JSOP Shares. The participants also hold a nil cost option over the EBT's interest in the JSOP Shares which may be exercised in certain circumstances. All dividend and voting rights in the JSOP Shares are waived whilst the JSOP Shares are jointly held by the relevant participant and the trustee of the EBT. 

 

1 Available on the Company's website at http://www.hydrodec.com/investor-relations/performance-and-reports/financial-reports.

 

For further information please contact:

 

Hydrodec Group plc

 

020 3300 1643

Ian Smale, Chief Executive

Chris Ellis, Chief Financial Officer

James Hodges, General Counsel and Company Secretary

 

 

 

Peel Hunt LLP (Nominated Adviser and Broker)

 

020 7418 8900

Justin Jones

Mike Bell

 

 

 

Vigo Communications (PR adviser to Hydrodec)

 

020 7016 9570

Patrick d'Ancona

Chris McMahon

 

 

Notes to Editors:

Hydrodec's technology is a proven, highly efficient, oil re-refining and chemical process initially targeted at the multi-billion US$ market for transformer oil used by the world's electricity industry. Hydrodec processes spent oil in the US and Australia with distinct competitive advantage delivered through very high recoveries (near 100%), producing 'as new' high quality oils at competitive cost and without environmentally harmful emissions. The process also completely eliminates PCBs, a toxic additive banned under international regulations. Hydrodec's plants are located at Canton, Ohio, US whilst in Australia, Hydrodec's operations are outsourced to Southern Oil's Refinery at Bomen, New South Wales, Australia. In 2013, Hydrodec acquired the business and assets of OSS Group, the UK's largest collector, consolidator and processor of used lubricant oil and seller of processed fuel oil, with a national network of oil storage and transfer stations. Used oil is converted into processed fuel oil at OSS's plant at Stourport and principally sold on to the UK quarry and power industry. In April 2015, Hydrodec further acquired the business and assets of Eco Oil, a leading UK waste oil collector and supplier of recycled industrial fuel oil into the power and road stone industries. It is also one of four significant providers of waste management services to the marine industry in the UK, specifically oily-water slops or marine pollutant (MARPOL). In line with our stated intention to develop a base oil re-refinery in the UK, we have an exclusive licence agreement with California-based Chemical Engineering Partners (CEP) to develop the CEP wiped-film evaporation and hydrogenation technology in the UK as well as the basic engineering for a 75 million litre per annum capacity base oil re-refinery. In February 2015, we moved the Group's head office to more cost effective serviced offices at 6 Hays Lane, London Bridge, London SE1 2HB.

Hydrodec's shares are listed on the AIM Market of the London Stock Exchange. For further information, please visit www.hydrodec.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBUGDUXXGBGUL
Date   Source Headline
8th Oct 20189:00 amRNSPrice Monitoring Extension
8th Oct 20187:00 amRNSProposed placing to raise a minimum of £10m
28th Sep 20183:45 pmRNSBusiness Review Update
10th Sep 20187:00 amRNSHalf-year Report
22nd Aug 20187:00 amRNSRe-refining technology patent extended to Europe
15th Aug 20183:27 pmRNSHolding(s) in Company
3rd Aug 20187:00 amRNSTrading Update
27th Jun 201812:10 pmRNSResult of AGM
4th Jun 20182:32 pmRNS2017 Annual Report and Accounts and Notice of AGM
31st May 20181:39 pmRNSDirector/PDMR Shareholding
31st May 201812:05 pmRNSFinal Results
25th May 20187:00 amRNSChange of Adviser
2nd May 20187:00 amRNSQ1 Trading Update
4th Apr 20187:00 amRNSDirectorate Change
29th Jan 20187:00 amRNSPre-close Trading Update
28th Dec 20177:00 amRNSExtension of working capital facilities
16th Nov 20172:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20175:16 pmRNSHolding(s) in Company
31st Oct 201711:38 amRNSHolding(s) in Company
27th Oct 20177:00 amRNSGrant of options
26th Oct 20177:00 amRNSQ3 Trading Update
5th Oct 20177:00 amRNSHolding(s) in Company
25th Sep 20177:00 amRNSHalf Yearly Report
18th Sep 20177:00 amRNSNew patent
12th Jul 20177:00 amRNSCarbon Credit Service Agreement
27th Jun 201711:00 amRNSResult of AGM
27th Jun 20177:00 amRNSAGM Statement
2nd Jun 20179:32 amRNS2016 Annual Report and Accounts and Notice of AGM
12th May 20177:00 amRNSFinal Results
8th May 20177:00 amRNSInitial Sale of Carbon Credits
12th Apr 20177:00 amRNSQ1 2017 Trading Update
11th Apr 20174:11 pmRNSHolding(s) in Company
14th Feb 201710:52 amRNSHolding(s) in Company
14th Feb 201710:48 amRNSHolding(s) in Company
30th Jan 20177:00 amRNSPre-close Trading Update
24th Jan 201711:45 amRNSHolding(s) in Company
12th Dec 20167:00 amRNSTrading Update
20th Oct 201611:30 amRNSHolding(s) in Company
17th Oct 20167:00 amRNSAdditional Investment in Hydrodec of North America
11th Oct 201611:20 amRNSHolding(s) in Company
3rd Oct 20161:30 pmRNSChange of Registered Office
16th Sep 20167:00 amRNSHalf Yearly Report
8th Sep 20167:00 amRNSCarbon Credit Project Approval
18th Aug 20167:00 amRNSContract Win
21st Jul 20165:00 pmRNSHolding(s) in Company
20th Jul 20167:00 amRNSTrading Update
24th Jun 20164:58 pmRNSDirector/PDMR Shareholding
14th Jun 201612:50 pmRNSHolding(s) in Company
10th Jun 201612:53 pmRNSDirector's shareholding
9th Jun 20165:35 pmRNSDirectors' shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.